Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans

Molecular Nutrition and Food Research

Volumn 53, Issue SUPPL. 1, 2009, Pages

  Stalmach, Angélique ^a   Troufflard, Stéphanie ^a   Serafini, Mauro ^b   Crozier, Alan ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Istituto Nazionale di Ricerca   (Italy)

Author keywords

Flavan 3 ols; Glucuronide; Green tea; Methyl; Urinary excretion

Indexed keywords

CATECHIN; DRUG DERIVATIVE; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; FLAVAN 3 OL; FLAVAN-3-OL; FLAVONOID; GALLOCATECHIN;

ARTICLE; BLOOD; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINE ABSORPTION; TEA; URINE;

CATECHIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLAVONOIDS; HUMANS; INTESTINAL ABSORPTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TEA;

EID: 67649934106     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800169     Document Type: Article

References (35)

1. Barbosa, D. S., Green tea polyphenolic compounds and human health, J. Verbr. Lebensm. 2007, 2, 407-413.
2. Cabrera, C., Artacho, R., Giménez, R., Beneficial effects of green tea - A review, J. Am. Coll. Nutr. 2006, 25, 79-99.
3. Zaveri, N. T., Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications, Life Sci. 2006, 78, 2073-2080.
4. Yang, C. S., Lambert, J. D., Ju, J., Lu, G., et al., Tea and cancer prevention: Molecular mechanisms and human relevance, Toxicol. Appl. Pharmacol. 2006, 224, 265-273.
5. Gao, Y. T., McLaughlin, J. K., Blot, W. J., Ji, B. T., et al., Reduced risk of oesophageal cancer associated with green tea consumption, J. Nat. Cancer Inst. 1994, 86, 855-858.
6. Ji, B. T., Chow, W. H., Hsing, A. W., McLaughlin, J. K., et al., Green tea consumption and the risk of pancreatic and colorectal cancers, Int. J. Cancer 1997, 70, 255-258.
7. Suzuki, Y., Tsubono, Y., Nakaya, N., Koizumi, Y., et al., Green tea and the risk of colorectal cancer: Pooled analysis of two prospective studies in Japan, J. Epidemiol. 2005, 15, 118-124.
8. Kuriyama, S., Shimazu, T., Ohmori, K., Kikuchi, N., et al., Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The Ohsaki study, JAMA 2006, 296, 1255-1265.
9. Stangl, V., Lorenz, M., Stangl, K., The role of tea and tea flavonoids in cardiovascular health, Mol. Nutr. Food Res. 2006, 50,218-228.
10. Iso, H., Date, C., Wakai, K., Fukui, M., et al., The relationship between green tea and total caffeine intake and risk for self-reported type-2 diabetes among Japanese adults, Ann. Int. Med. 2006, 144, 554-562.
11. n analysis of phenolic compounds and purine alkaloids in green and black tea, J. Agric. Food Chem. 2004, 52, 2807-2015.
12. Stewart, A. J., Mullen, W., Crozier, A., On-line high-performance liquid chromatography analysis of the antioxidant activity of phenolic compounds in green and black tea, Mol. Nutr. Food Res. 2005, 49, 52-60.
13. Shao, W., Powell, C., Clifford, M. N., The analysis by HPLC of green, black and Pu'er teas produced in Yemen, J. Sci. Food Agric. 1995, 69, 535-540.
14. Henning, S. M., Niu, Y., Liu, Y., Lee, N. H., et al., Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals, J. Nutr. Biochem. 2005, 16, 610-616.
15. van het Hof, K. H., Wiseman, S. A., Yang, C. S., Tijburg, L. B., Plasma and lipoprotein levels of tea catechins following repeated tea consumption, Proc. Soc. Exp. Biol. Med. 1999, 220,203-209.
16. Chow, H. H., Cai, Y., Alberts, D. S., Hakim, I., et al., Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E, Cancer Epidemiol. Biomark. Prev. 2001, 10, 53-58.
17. Unno, T., Kondo, K., Itakura, H., Takeo, T., Analysis of (-)-epigallocatechin gallate in human serum obtained after ingesting green tea, Biosci. Biotechnol. Biochem. 1996, 60, 2066-2068.
18. Ullmann, U., Haller, J., Decourt, J. P., Girault, N., et al., A single ascending dose study of epigallocatechin gallate in healthy volunteers, J. Int. Med. Res. 2003, 31, 88-101.
19. Lee, M. J., Wang, Z. Y., Li, H., Chen, L., et al., Analysis of plasma and urinary tea polyphenols in human subjects, Cancer Epidemiol. Biomark. Prev. 1995, 4, 393-399.
20. Henning, S. M., Niu, Y. T., Lee, N. H., Thames, G. D., et al., Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement, Am. J. Clin. Nutr. 2004, 80, 1558-1564.
21. Li, C., Lee, M. J., Sheng, S., Meng, X., et al., Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion, Chem. Res. Toxicol. 2000, 13, 177-184.
22. Meng, X., Lee, M. J., Li, C., Sheng, S., et al., Formation and identification of 49-O-methyl-(-)-epigallocatechin in humans. Drug Metab. Dispos. 2001, 29, 789-793.
23. Day, A. J., Mellon, F., Barron, D., Sarrazin, G., et al., Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin, Free Rad. Res. 2001, 35, 941-952.
24. Natsume, M., Osakabe, N., Oyama, M., Sasaki, M., et al., Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: differences between human and rat, Free Rad. Biol. Med. 2003, 34,840-849.
25. Shahrzad, S., Bitsch, I., Determination of gallic acid and its metabolites in human plasma and urine by high-performance liquid chromatography, J. Chromatogr. B 1998, 705, 87-95.
26. Shahrzad, S., Aoyagi, K., Winter, A., Koyama, A., Bitsch, I., Pharmacokinetics of gallic acid and its relative bioavailability from tea in humans, J. Nutr. 2001, 131, 1207-1210.
27. Manach, C., Williamson, G., Morand, C., Scalbert, A., Rémésy, C., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies, Am. J. Clin. Nutr. 2005, 81, 230S-242S.
28. Donovan, J. L., Manach, C., Fauks, R. M., Kroon, P. A., in: Crozier, A., Clifford, M. N., Ashihara, H. (Eds.), Plant Secondary Metabolites: Occurrence, Structure and Role in the Human Diet, Blackwell Publishing, Oxford 2006, pp. 303-351.
29. Auger, C., Hara, Y., Crozier, A., Bioavailability of Polyphenon E flavan-3-ols in humans with an ileostomy, J. Nutr. 2008, 138, 1535S-1542S.
30. Yang, C. S., Lee, M.-J., Chen, L., Human salivary tea catechin levels and catechin esterase activities: Implication in human cancer prevention studies, Cancer Epidemiol. Biomark. Prev. 1999, 8, 83-89.
31. Kida, T., Suzuki, Y., Matsumoto, N., Nanjo, F., et al., Identification of biliary metabolites of (-)-epigallocatechin gallate in rats, J. Agric. Food Chem. 2000, 48, 4151-4155.
32. 3H]epigallocatechin gallate and its metabolic fate in rats after intravenous administration, J. Agric. Food Chem. 2001,49,1042-1048.
33. Mullen, W., Edwards, C. A., Crozier, A., Absorption, excretion and metabolic profiling of methyl-, glucuronyl-, glucosyl and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions, Brit. J. Nutr. 2006, 96, 107-116.
34. Mullen, W., Archeveque, M.-A., Edwards, C. A., Crozier, A., Bioavailability and metabolites of orange juice flavones in humans: impact of a full fat yoghurt, J. Agric. Food Chem., in press.
35. Mullen, W., Edwards, C. A., Serafini, M., Crozier, A., Bioavailability of pelargonidin-3-glucoside and its metabolites in humans following the ingestion of strawberries with and without cream, J. Agric. Food Chem. 2008, 56, 713-719.